Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Göran Ahlgren

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Prostatic Neoplasms

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Anatomy

Prostate

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
9
Abrahamsson, Per-Anders
7
Aus, Gunnar
7
Hugosson, Jonas
5
Lundberg, S
2
Pedersen, K
2
Schain, Moddy
2
Schelin, Sonny
2
Gadaleanu, Virgil
1
Giwercman, Aleksander
1
Giwercman, Yvonne Lundberg
1
Bergdahl, Svante
1
Flodgren, Per
1
Strand, Sven-Erik
1
Tennvall, Jan
1
Garkavij, Michael

Sign-in to see all Coauthors

Publications

TOP 3
Giwercman Yvonne L; Abrahamsson Per-Anders; Giwercman Aleksander; Gadaleanu Virgil; Ahlgren Göran
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
Aus G; Abrahamsson P-A; Ahlgren G; Hugosson J; Lundberg S; Schain M; Schelin S; Pedersen K
Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial.
Tennvall J; Abrahamsson P A; Ahlgren G; Darte L; Flodgren P; Garkavij M; Strand S E
Palliative radiation with a radiolabeled diphosphonate (rhenium-186 etidronate) in patients with hormone-refractory disseminated prostate carcinoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Göran Ahlgren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2005: Giwercman Yvonne L; Abrahamsson Per-Anders; Giwercman Aleksander; Gadaleanu Virgil; Ahlgren Göran
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
European urology 2005;48(4):679-85.
2002: Aus G; Abrahamsson P-A; Ahlgren G; Hugosson J; Lundberg S; Schain M; Schelin S; Pedersen K
Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial.
BJU international 2002;90(6):561-6.
2000: Tennvall J; Abrahamsson P A; Ahlgren G; Darte L; Flodgren P; Garkavij M; Strand S E
Palliative radiation with a radiolabeled diphosphonate (rhenium-186 etidronate) in patients with hormone-refractory disseminated prostate carcinoma.
Scandinavian journal of urology and nephrology 2000;34(3):188-93.
2000: Ahlgren G; Pedersen K; Lundberg S; Aus G; Hugosson J; Abrahamsson P A
Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment.
The Prostate 2000;42(4):274-9.
1999: Ahlgren G; Falkmer U; Gadaleanu V; Abrahamsson P A
Evaluation of DNA ploidy combined with a cytometric proliferation index of imprints from core needle biopsies in prostate cancer.
European urology 1999;36(4):314-9.
1999: Ahlgren G; Pedersen K; Lundberg S; Aus G; Hugosson J; Abrahamsson P A
Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy.
Urology 1999;54(2):329-34.
1998: Aus G; Abrahamsson P A; Ahlgren G; Hugosson J; Lundberg S; Schain M; Schelin S; Pedersen K
Hormonal treatment before radical prostatectomy: a 3-year followup.
The Journal of urology 1998;159(6):2013-6; discussion 2016-7.
1997: Aus G; Ahlgren G; Hugosson J; Pedersen K V; Rensfeldt K; Söderberg R
Diagnosis of prostate cancer: optimal number of prostate biopsies related to serum prostate-specific antigen and findings on digital rectal examination.
Scandinavian journal of urology and nephrology 1997;31(6):541-4.
1997: Ahlgren G; Lindholm K; Falkmer U; Abrahamsson P A
A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Urology 1997;50(3):379-84.
1996: Aus G; Ahlgren G; Bergdahl S; Hugosson J
Infection after transrectal core biopsies of the prostate--risk factors and antibiotic prophylaxis.
British journal of urology 1996;77(6):851-5.
1996: Hugosson J; Abrahamsson P A; Ahlgren G; Aus G; Lundberg S; Schelin S; Schain M; Pedersen K
The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment.
European urology 1996;29(4):413-9.

Sign-in to see more